Anti-tumor Effects of Triterpenoids in Leukemia
Author Information
Author(s): Kress Christina L., Konopleva Marina, Martínez-García Vanesa, Krajewska Maryla, Lefebvre Sophie, Hyer Marc L., McQueen Teresa, Andreeff Michael, Reed John C., Zapata Juan M.
Primary Institution: Burnham Institute for Medical Research
Hypothesis
Can synthetic triterpenoids effectively reduce tumor burden in chronic lymphocytic leukemia (CLL) using a transgenic mouse model?
Conclusion
Synthetic triterpenoids CDDO and CDDO-Im significantly reduce leukemia and lymphoma burden in a transgenic mouse model of CLL.
Supporting Evidence
- CDDO-Im was shown to be over 10-fold more potent than CDDO in inducing apoptosis.
- Treatment with CDDO-Im resulted in over 90% reduction of B cells in blood.
- CDDO-Im treatment caused little effect on normal B and T cells.
Takeaway
Researchers found that a special type of medicine made from plants can help fight a kind of blood cancer in mice.
Methodology
The study used transgenic mice with CLL to test the effects of CDDO and CDDO-Im on tumor cells both ex vivo and in vivo.
Potential Biases
Potential bias in the selection of treatment dosages and the interpretation of results.
Limitations
The study was conducted in a mouse model, which may not fully replicate human responses.
Participant Demographics
Transgenic mice with chronic lymphocytic leukemia.
Statistical Information
P-Value
0.0005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website